The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man
Abstract
Neuropeptide Y-like immunoreactivity (NPY-LI) and catecholamine concentrations in plasma were analysed during and after 60 min of physical exercise at a work load corresponding to 70% of individual maximal oxygen uptake in nine healthy men of average physical fitness. Systemic plasma NPY-LI increased progressively from 18 +/- 3 to 81 +/- 19 pmol X 1(-1) in parallel with a 10-fold increase in noradrenaline (NA) concentration. The increase in plasma NPY-LI during exercise and the decrease after completion of exercise were much slower than the corresponding changes in NA concentration. This difference is probably related to a slower diffusion of NPY into systemic circulation after release, as well as to a longer half-life of NPY than of NA in plasma. Reversed phase HPLC and sephadex G-50 gel-filtration chromatography revealed that the main component of NPY-LI in plasma during exercise eluted in a similar position as synthetic human NPY. During exercise plasma NPY-LI correlated well with the plasma concentration of NA (r = 0.80), but not with that of adrenaline (ADR), suggesting a neuronal origin of NPY. The self-ratings of perceived exertion (RPE) were well correlated with the plasma concentrations of both NPY-LI and NA. No clear-cut veno-arterial concentration difference was observed for NPY-LI. Isometric handgrip and orthostatic test doubled plasma NA concentrations but did not cause any increase in plasma NPY-LI. No change in plasma tachykinin-like immunoreactivity was detected during exercise. The present data suggest that NPY is released together with NA during strong, but probably not during mild, sympathetic activation under physiological conditions in man.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NPY is an excellent indicator of sympathetic activity, 34 which is more stable and has a significantly longer half life in plasma.35”
Citations
Cites
Perceived exertion as an indicator of somatic stress
Borg, G. (1970) · Journal of Rehabilitation Medicine · doi:10.2340/1650197719702239298 · Cited by 4,723
A Flexible System of Enzymatic Analysis
Lowry, O. H., & Passonneau, J. V. (1972) · Elsevier eBooks · doi:10.1016/b978-0-12-457950-7.x5001-3 · Cited by 4,050
Åstrand, P. O., & Ryhming, I. (1954) · Journal of Applied Physiology · doi:10.1152/jappl.1954.7.2.218 · Cited by 1,558
Neuropeptide Y: complete amino acid sequence of the brain peptide.
Tatemoto, K. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.18.5485 · Cited by 1,378
Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., Martling, C., Tatemoto, K., Mutt, V., Polak, J. M., Bloom, S. R., & Goldstein, M. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07171.x · Cited by 1,199
Self-citationNeuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers
Ekblad, E., Edvinsson, L. I., Wahlestedt, C., Uddman, R., Håkanson, R., & Sundler, F. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90064-8 · Cited by 741
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man
Lundberg, J. M., Terenius, L. Y., Hökfelt, T. G. M., & Goldstein, M. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90401-9 · Cited by 616
Self-citationHjemdahl, P., Daleskog, M., & Kahan, T. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90384-9 · Cited by 564
Self-citationCoexistence of peptides and classical neurotransmitters
Lundberg, J. M., & Hökfelt, T. G. M. (1983) · Trends in Neurosciences · doi:10.1016/0166-2236(83)90149-2 · Cited by 560
Self-citationLundberg, J. M., & Tatemoto, K. (1982) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1982.tb07157.x · Cited by 534
Self-citation
Research works printed but not linked: 3
- Hohorst H. J., 1962, Metoden der Enzymatischen Analyse, 266
- LundbergJ. M. PernowJ. FriedG.&ÄnggårdA.(1986c)Neuropeptide Y in relation to reserpine and adrenoceptor antagonst‐resistant sympathetic vascular effects in the cat spleen.Nauny‐Schmiedeberg's Arch Pharmacol in press.
- Simpson G. G., 1960, Quantitative Zoology, 232
Cited by
Sorted by citations
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues
Dumont, Y., Martel, J.-C., Fournier, A., St-Pierre, S. A., & Quirion, R. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90038-g · Cited by 380
Impaired sympathetic vascular regulation in humans after acute dynamic exercise.
Halliwill, J. R., Taylor, J. A., & Eckberg, D. L. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021592 · Cited by 381
Plasma neuropeptide-Y concentrations in humans exposed to military survival training
Morgan, C. A., Wang, S., Southwick, S. M., Rasmusson, A., Hazlett, G., Hauger, R. L., & Charney, D. S. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00239-5 · Cited by 298
Neuropeptide Y: the universal soldier
Pedrazzini, T., Pralong, F. P., & Grouzmann, E. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s000180300029 · Cited by 289
Kaye, D. M., Lambert, G. W., Lefkovits, J., Morris, M. J., Jennings, G., & Esler, M. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90738-2 · Cited by 285
Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD
Rasmusson, A. M., Hauger, R. L., Morgan, C. A., Bremner, J. D., Charney, D. S., & Southwick, S. M. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00185-7 · Cited by 255
Neuropeptide Y as an autonomic neurotransmitter
Potter, E. K. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90028-9 · Cited by 233
Żukowska-Grójec, Z. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44683.x · Cited by 229
A possible role of neuropeptide Y in depression and stress
Morales‐Medina, J. C., Dumont, Y., & Quirion, R. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.077 · Cited by 217
Role of hypothalamic neuropeptide Y in feeding and obesity
Gehlert, D. R. (1999) · Neuropeptides · doi:10.1054/npep.1999.0057 · Cited by 209
Chromogranin A in heart failure. A novel neurohumoral factor and a predictor for mortality
Ceconi, C. (2002) · European Heart Journal · doi:10.1053/euhj.2001.2977 · Cited by 205
Lundberg, J. M., Rudehill, A., Sollevi, A., Fried, G. M., & Wallin, G. B. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90193-0 · Cited by 185
Self-citationNeuropeptide Y stimulates neuronal precursor proliferation in the post‐natal and adult dentate gyrus
Howell, O. W., Doyle, K. L., Goodman, J. H., Scharfman, H. E., Herzog, H., Pringle, A. K., Beck‐Sickinger, A. G., & Gray, W. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03057.x · Cited by 182
Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans
Eckberg, D. L., Rea, R. F., Andersson, O., Hedner, T., Pernow, J., Lundberg, J. M., & Wallin, B. G. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08401.x · Cited by 171
Self-citationNonnoradrenergic mechanism of reflex cutaneous vasoconstriction in men
Stephens, D. P., Aoki, K., Kosiba, W. A., & Johnson, J. M. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1496 · Cited by 145
Plasma catecholamines—analytical challenges and physiological limitations
Hjemdahl, P. (1993) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80179-x · Cited by 143
Self-citationZhang, X.-Q., Bao, L., Xu, Q., Kopp, J., Arvidsson, U., Elde, R., & Hökfelt, T. G. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11738 · Cited by 137
Neuropeptide Y effector systems: perspectives for drug development
Grundemar, L., & Håkanson, R. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90076-0 · Cited by 137
Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans
Stephens, D. P., Saad, A. R., Bennett, L. A. T., Kosiba, W. A., & Johnson, J. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00061.2004 · Cited by 130
Neuropeptide Y and Sympathetic Neurotransmissiona
Lundberg, J. M., Franco‐Cereceda, A., Lacroix, J., & Pernow, J. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb48930.x · Cited by 120
Self-citationKallio, J., Pesonen, U., Kaipio, K., Karvonen, M., Jaakkola, U., Heinonen, O. J., Uusitupa, M., & Koulu, M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0436fje · Cited by 143
Härle, P., Straub, R. H., Wiest, R., Mayer, A., Schölmerich, J., Atzeni, F., Carrabba, M., Cutolo, M., & Sarzi-Puttini, P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.038059 · Cited by 114
The Shared Neuroanatomy and Neurobiology of Comorbid Chronic Pain and PTSD
Scioli, E. R., Forman, D. E., Otis, J. D., Gregor, K. L., Valovski, I. T., & Rasmusson, A. M. (2014) · Clinical Journal of Pain · doi:10.1097/ajp.0000000000000115 · Cited by 122
Erlinge, D., Brunkwall, J. S., & Edvinsson, L. I. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90006-x · Cited by 110
Origin and Actions of Neuropeptide Y in the Cardiovascular System
Żukowska-Grójec, Z., & Wahlestedt, C. (1993) · Humana Press eBooks · doi:10.1007/978-1-59259-465-8_8 · Cited by 109
Region-Specific Neuropeptide Y Overflows at Rest and During Sympathetic Activation in Humans
Morris, M. J., Cox, H. S., Lambert, G. W., Kaye, D. M., Jennings, G., Meredith, I. T., & Esler, M. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.137 · Cited by 107
Pharmacology of noradrenaline and neuropeptide tyrosine (NPY)‐mediated sympathetic cotransmission
Lundberg, J. O., Franco‐Cereceda, A., Hemsén, A., Js, L., & Pernow, J. (1990) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1990.tb00692.x · Cited by 103
Self-citationPhysical stress and catecholamine release
Kjær, M., Secher, N. H., & Galbo, H. (1987) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80064-2 · Cited by 101
Herring, N., Cranley, J. J., Lokale, M. N., Li, D., Shanks, J. A., Alston, E. N., Girard, B. M., Carter, E., Parsons, R. L., Habecker, B. A., et al. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.016 · Cited by 98
Grundemar, L., & Håkanson, R. (1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90151-m · Cited by 94
Pernow, J., Öhlén, A., Hökfelt, T. G. M., Nilsson, O., & Lundberg, J. M. (1987) · Regulatory Peptides · doi:10.1016/0167-0115(87)90173-x · Cited by 88
Self-citationLambert, G. W., Kaye, D. M., Lefkovits, J., Jennings, G., Turner, A., Cox, H. S., & Esler, M. (1995) · Circulation · doi:10.1161/01.cir.92.7.1813 · Cited by 86
Chromogranin A in heart failure
Wollert, K. C. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3132 · Cited by 86
Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats
Żukowska-Grójec, Z., Konarska, M., & McCarty, R. C. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90440-7 · Cited by 84
α‐Adrenergic Vascular Responsiveness during Postexercise Hypotension in Humans
Halliwill, J. R., Dinenno, F. A., & Dietz, N. M. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.042838 · Cited by 83
Botulinum neurotoxin A attenuates release of norepinephrine but not NPY from vasoconstrictor neurons
Morris, J. L., Jobling, P., & Gibbins, I. L. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00477.2002 · Cited by 80
NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells
Cavadas, C., Silva, A. P., Mosimann, F., Cotrim, M. D., Ribeiro, C., Brunner, H. R., & Grouzmann, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.12.5956 · Cited by 75
Irwin, M. R., Hauger, R. L., & Brown, M. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505449 · Cited by 75
Release of immunoreactive-neuropeptide Y by rat platelets
Myers, A. K., Farhat, M. Y., Vaz, C. A., Keiser, H. R., & Żukowska-Grójec, Z. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81057-x · Cited by 74
TAKIYYUDDIN, M. A., Brown, M. R., Dinh, T., Cervenka, J. H., Braun, S. D., Parmer, R. J., Kennedy, B. P., & O’Connor, D. T. (1994) · Journal of Autonomic Pharmacology · doi:10.1111/j.1474-8673.1994.tb00601.x · Cited by 70
Evidence for co‐transmitter role of neuropeptide Y in the pig spleen
Lundberg, J. M., Rudehill, A., Sollevi, A., & Hamberger, B. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb11868.x · Cited by 70
Self-citationSchalling, M., Franco‐Cereceda, A., Hemsén, A., Dagerlind, Å., Seroogy, K. B., Persson, H., Hökfelt, T. G. M., & Lundberg, J. M. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90365-u · Cited by 68
Self-citationJidéus, L., Joachimsson, P.-O., Stridsberg, M., Ericson, M. O., Tydén, H., Nilsson, L., Blomström, P., & Blomström‐Lundqvist, C. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)02631-5 · Cited by 67
Elevated Insulin, Norepinephrine, and Neuropeptide Y in Hypertension
Solt, V. B., Brown, M. R., Kennedy, B. P., Kolterman, O., & Ziegler, M. G. (1990) · American Journal of Hypertension · doi:10.1093/ajh/3.11.823 · Cited by 67
NPY Y1 Receptors Are Present in Axonal Processes of DRG Neurons
Brumovsky, P. R., Shi, T. J., Matsuda, H., Kopp, J., Villar, M. J., & Hökfelt, T. G. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2001.7845 · Cited by 66
Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y.
Warner, M. R., & Levy, M. N. (1989) · Circulation Research · doi:10.1161/01.res.65.6.1536 · Cited by 64
Lundberg, J. M., Hemsén, A., Rudehill, A., Härfstrand, A., Larsson, O., Sollevi, A., Saria, A., Hökfelt, T. G. M., Fuxé, K., & Fredholm, B. B. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90359-4 · Cited by 63
Self-citationNPY and Gene Therapy for Epilepsy: How, When,... and Y
Cattaneo, S., Verlengia, G., Marino, P., Simonato, M., & Bettegazzi, B. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.608001 · Cited by 64
Nilsson, C. L., Karlsson, G., Blennow, K., Heilig, M. A., & Ekman, R. (1996) · Peptides · doi:10.1016/0196-9781(96)00013-7 · Cited by 60
Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated
Żukowska-Grójec, Z., Shen, G. H., Capraro, P. A., & Vaz, C. A. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90317-h · Cited by 59
Neuropeptide Y and neurovascular control in skeletal muscle and skin
Hodges, G. J., Jackson, D. N., Mattar, L., Johnson, J. M., & Shoemaker, J. K. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00157.2009 · Cited by 58
Role of neuropeptide Y (NPY) in cardiovascular responses to stress
Zukowska‐Grojec, Z., & Vaz, A. (1988) · Synapse · doi:10.1002/syn.890020319 · Cited by 58
Edvinsson, L. I., Ekman, R., & Thulin, T. (1991) · Regulatory Peptides · doi:10.1016/0167-0115(91)90021-8 · Cited by 57
Aaser, E., Gullestad, L. L., Tølløfsrud, S., Lundberg, J. O., Hall, C., Djøseland, O., KJEKSHUS, J. K., & Forfang, K. (1997) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519709099409 · Cited by 54
Self-citationSympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.
Warner, M. R., Senanayake, P. D., Ferrario, C. M., & Levy, M. N. (1991) · Circulation Research · doi:10.1161/01.res.69.2.455 · Cited by 54
Li, L., Jönsson‐Rylander, A., Abe, K., & Żukowska, Z. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000179601.19888.19 · Cited by 50
Mejía, J. A., Pernow, J., von Holst, H., Rudehill, A., & Lundberg, J. M. (1988) · Journal of neurosurgery · doi:10.3171/jns.1988.69.6.0913 · Cited by 50
Self-citationMorris, J. L., & Murphy, R. (1988) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(88)90124-5 · Cited by 50
Plasma neuropeptide Y in the symptomatic limb of patients with causalgic pain
Drummond, P. D., Finch, P. M., Edvinsson, L. I., & Goadsby, P. J. (1994) · Clinical Autonomic Research · doi:10.1007/bf01845774 · Cited by 49
Angina pectoris. Clinical characteristics, neurophysiological and molecular mechanisms
Sylvén, C. (1989) · Pain · doi:10.1016/0304-3959(89)90019-5 · Cited by 49
Functional organization of peripheral vasomotor pathways
Gibbins, I. L., Jobling, P., & Morris, J. L. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01079.x · Cited by 46
AHLBORG, G., Weitzberg, E., Sollevi, A., & Lundberg, J. M. (1992) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1992.tb09349.x · Cited by 46
Self-citationStress elicits trans-synaptic activation of adrenal neuropeptide Y gene expression
Hiremagalur, B., Květňanský, R., Nankova, B. B., Fleischer, J., Geertman, R. T., Fukuhara, K., Viskupic, E., & Sabban, E. L. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90194-5 · Cited by 44
Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass
Adams, D. C., Heyer, E. J., Simon, A. E., Delphin, E., Rose, E. A., Öz, M. C., McMahon, D. J., & Sun, L. S. (2000) · Critical Care Medicine · doi:10.1097/00003246-200002000-00003 · Cited by 44
Kaijser, L., Pernow, J., Berglund, B., & Lundberg, J. M. (1990) · Clinical Physiology · doi:10.1111/j.1475-097x.1990.tb00252.x · Cited by 44
Self-citationCardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
Feng, Q., Hedner, T., Andersson, B., Lundberg, J. M., & Waagstein, F. (1994) · Heart · doi:10.1136/hrt.71.3.261 · Cited by 42
Self-citationEffect of neuropeptide Y on jejunal water and ion transport in humans
Holzer‐Petsche, U., Petritsch, W., Hinterleitner, T. A., Eherer, A. J., Sperk, G., & Krejs, G. J. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90007-8 · Cited by 42
Neuroendocrine changes in chronic cardiac failure
Nicholls, D., Onuoha, G. N., McDowell, G., Elborn, J. S., Riley, M., Nugent, A. M., Steele, I. C., Shaw, C., & Buchanan, K. D. (1996) · Basic Research in Cardiology · doi:10.1007/bf00810519 · Cited by 42
Gullestad, L. L., Jørgensen, B., Bjurö, T., Pernow, J., Lundberg, J. M., Dota, C., Hall, C., Simonsen, S., & Åblad, B. (2000) · Circulation · doi:10.1161/01.cir.102.9.987 · Cited by 41
Self-citationUllman, B., Franco-Cereceda, A., Hulting, J., Lundberg, J. M., & Sollevi, A. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00283.x · Cited by 41
Self-citationEdvinsson, L. I., Ekman, R., Hedner, P., & Valdemarsson, S. V. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01796.x · Cited by 40
Morphological and Molecular Changes of the Myocardium After Left Ventricular Mechanical Support
Baba, H. A., & Wohlschlaeger, J. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160606 · Cited by 39
Role of Neuropeptide Y in Cold Stress-Induced Hypertension
Han, S., Chen, X., Cox, B. F., Yang, C.-L., Wu, Y., Naes, L., & Westfall, T. C. (1998) · Peptides · doi:10.1016/s0196-9781(97)00297-0 · Cited by 38
Current Insights Into the Role of Neuropeptide Y in Skin Physiology and Pathology
Anderson, Z. T., Dawson, A. D., Slominski, A. T., & Harris, M. L. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838434 · Cited by 37
Lacroix, J. S., Stjärne, P., Änggård, A., & Lundberg, J. M. (1988) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1988.tb08398.x · Cited by 37
Self-citationGordon, A., Tyni‐Lenné, R., Jansson, E., Kaijser, L., Theodorsson-Norheim, E., & Sylvén, C. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90002-6 · Cited by 37
Self-citationUncoupling of sympathetic nervous system and hypothalamic‐pituitary‐adrenal axis in cirrhosis
Wiest, R., Moleda, L., Zietz, B., Hellerbrand, C., Schölmerich, J., & Straub, R. H. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05456.x · Cited by 37
Kallio, J., Pesonen, U., Jaakkola, U., Karvonen, M. K., Helenius, H. Y. M., & Koulu, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021957 · Cited by 35
Peripheral Autonomic Nervous System
Gibbins, I. L. (1990) · Elsevier eBooks · doi:10.1016/b978-0-12-547625-6.50010-6 · Cited by 35
Torres, G. E., Marcela Bitran, C., & Huidobro-Toro, J. P. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90799-d · Cited by 35
The biochemical assessment of sympathoadrenal activity in man
Christensen, N. J. (1991) · Clinical Autonomic Research · doi:10.1007/bf01826215 · Cited by 37
Söderman, C., Eriksson, L. S., JUHLIN‐DANNFELT, A., Lundberg, J. M., Broman, L. M., & Holmgren, A. (1993) · Clinical Physiology · doi:10.1111/j.1475-097x.1993.tb00482.x · Cited by 34
Self-citationLehmann, J. C. (1990) · Drug Development Research · doi:10.1002/ddr.430190402 · Cited by 34
Scioli, E. R., Forman, D. E., Otis, J. D., Tun, C. G., Allsup, K., Marx, C. E., Hauger, R. L., Shipherd, J. C., Higgins, D. M., Tyzik, A. L., et al. (2016) · The Journal of Rehabilitation Research and Development · doi:10.1682/jrrd.2014.10.0267 · Cited by 35
Ericson, M. O. (2001) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430152581341 · Cited by 32
Renal hemodynamic responses to dynamic exercise in rabbits
Mueller, P. J., O’Hagan, K. P., Skogg, K. A., Buckwalter, J. B., & Clifford, P. S. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.5.1605 · Cited by 32
AHLBORG, G., & Lundbergt, J. M. (1996) · Clinical Physiology · doi:10.1111/j.1475-097x.1996.tb00741.x · Cited by 31
Żukowska-Grójec, Z., Golczynska, M., Shen, G. H., Torres-Duarte, A. P., Haass, M., Wahlestedt, C., & Myers, A. K. (1993) · Pediatric Nephrology · doi:10.1007/bf01213372 · Cited by 31
Valdemarsson, S. V., Edvinsson, L. I., Ekman, R., Hedner, P., & SJÖHOLM, A. (1991) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1991.tb00452.x · Cited by 30
Neuropeptide Y inhibits relaxations of the guinea pig uterine artery produced by VIP
Morris, J. L. (1990) · Peptides · doi:10.1016/0196-9781(90)90096-n · Cited by 30
Medzikovic, L., van Roomen, C. P. A. A., Baartscheer, A., van Loenen, P. B., de Vos, J., Bakker, E. N. T. P., Koenis, D. S., Damanafshan, A., Creemers, E. E., Arkenbout, E. K., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy125 · Cited by 30
Plasma neuropeptide Y in anxiety disorders: findings in panic disorder and social phobia
Stein, M. B., Hauger, R. L., Dhalla, K. S., Chartier, M., & Asmundson, G. J. G. (1996) · Psychiatry Research · doi:10.1016/0165-1781(95)02776-9 · Cited by 29
Morris, J. L. (1989) · Springer eBooks · doi:10.1007/978-94-009-0835-2_12 · Cited by 29
Straub, R. H., Pongratz, G., Hirvonen, H., Pohjolainen, T., Mikkelsson, M., & Leirisalo‐Repo, M. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.089458 · Cited by 28
Morris, J. L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90145-7 · Cited by 28
Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia
Khatun, S., Kanayama, N., Belayet, H. M., Bhuiyan, A. B., Jahan, S., Begum, A., Kobayashi, T., & Terao, T. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70342-5 · Cited by 28
Morris, J. L. (1991) · Regulatory Peptides · doi:10.1016/0167-0115(91)90023-a · Cited by 28
Is neuropeptide Y a contributor to volume-induced hypertension?
Odar‐Cederlöf, I., ERICSSON, F., Theodorsson, E., & Kjellstrand, C. M. (1998) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(98)70049-6 · Cited by 27
Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y?
Buckwalter, J. B., Hamann, J. J., Kluess, H. A., & Clifford, P. S. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00071.2004 · Cited by 27
Kennedy, B. P., Shen, G. H., & Ziegler, M. G. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36566-8 · Cited by 27
Metadata
- Authors
- Pernow, J., Lundberg, J. M., Kaijser, L., Hjemdahl, P., Theodorsson‐Norheim, E., Martinsson, A., & Pernow, B.
- Affiliations
- Karolinska University Hospital (SE)
- Corresponding author
- Pernow, John
- Venue
- Clinical Physiology
- Publisher
- Wiley
- Published
- 1986-12
- Volume
- 6
- Issue
- 6
- Pages
- 561-578
- ISSN
- 0144-5979 (ISSN-L)
- 1365-2281
- OpenAlex
- W2029651085
- Cited by
- 211
- References
- 36
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2022: 3 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 4 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 2
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Physiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Cardiovascular and exercise physiology
- Health Sciences › Medicine › Physiology (medical) › Exercise and Physiological Responses
- Keywords
- neuropeptide Y, catecholamines, norepinephrine, epinephrine, sympathetic activation, physical activity, perceived exertion, tachykinins, isometric handgrip, orthostatic test
- MeSH terms
- Adult, Blood Pressure, Epinephrine, Physical Exertion, Heart Rate, Humans, Male, Neuropeptide Y, Neuropeptides, Norepinephrine, Radioimmunoassay, Sympathetic Nervous System, Time Factors, Tachykinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review